SuperCrowd
Annual report (amended) · Form C-AR/A
An amendment correcting or updating a company's annual report.
Bioclonetics Immunotherapeutics, Inc.
www.bioclonetics.com · TX · Filed May 2, 2019
Bioclonetics Immunotherapeutics, Inc. filed a Form C-AR/A — annual report (amended) — with the SEC on May 2, 2019.
| SEC file number | 020-23301 · every filing under this number |
|---|
Open the official record on EDGAR for this filing’s documents.
View the official filing on SEC EDGAR →The summary above is auto-extracted from the filing’s structured data on the SEC’s EDGAR system and shown for easy reading. Always confirm details against the official filing before acting. Inclusion here is not a recommendation or endorsement.